TrianglePUBLICATIONS · 34087126
Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Lancet Oncol
- Publication date
- 2021 Jun
- First author
- Dimopoulos MA
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Dimopoulos MA
- type
- Author
- name
- Terpos E
- type
- Author
- name
- Boccadoro M
- type
- Author
- name
- Delimpasi S
- type
- Author
- name
- Beksac M
- type
- Author
- name
- Katodritou E
- type
- Author
- name
- Moreau P
- type
- Author
- name
- Baldini L
- type
- Author
- name
- Symeonidis A
- type
- Author
- name
- Bila J
- type
- Author
- name
- Oriol A
- type
- Author
- name
- Mateos MV
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Dimopoulos MA
- type
- Author
- name
- Terpos E
- type
- Author
- name
- Boccadoro M
- type
- Author
- name
- Delimpasi S
- type
- Author
- name
- Beksac M
- type
- Author
- name
- Katodritou E
- type
- Author
- name
- Moreau P
- type
- Author
- name
- Baldini L
- type
- Author
- name
- Symeonidis A
- type
- Author
- name
- Bila J
- type
- Author
- name
- Oriol A
- type
- Author
- name
- Mateos MV
- type
- Author
- bibliography ids
- nci-bib-5b8417591dbd8a404bfb916b
- book metadata
- content sha256
- 102764cff544afb25e29578fe50a4ffa75f8407c6b36dce3ef5a4d89a69573f2
- document type
- citation
- dois
- 10.1016/S1470-2045(21)00128-5
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:34087126
- immutable id
- pubmed:34087126@102764cff544afb25e29578fe50a4ffa75f8407c6b36dce3ef5a4d89a69573f2
- journal
- abbreviation
- Lancet Oncol
- issn electronic
- 1474-5488
- issn print
- 1470-2045
- issue
- 6
- name
- The Lancet. Oncology
- nlm unique id
- 100957246
- pages
- 801-812
- volume
- 22
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 34087126
- provenance
- batch id
- 79f1021053e858d13ff3
- provider
- NCBI PubMed ESummary
- record sha256
- d220307b81ea170117a4a3cf132b39abc445cf16414d81f2e6647ef5f4f08a38
- response sha256
- 671d3d2962f73c698a1cb338d73222e2cc6cfdf61569f91b42612d5b59822e05
- retrieved at
- 2026-09-09T23:47:59.098265+00:00
- publication date
- display
- 2021 Jun
- precision
- month
- year
- 2021
- publication types
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial.
Preserved source evidence · Not medical advice